ID   SK-N-ASrOXALI4000(-)
AC   CVCL_RS97
DR   cancercelllines; CVCL_RS97
DR   Wikidata; Q54954432
RX   PubMed=28192521;
WW   https://www.wass-michaelislab.org/rccl.php
CC   Part of: Resistant Cancer Cell Line (RCCL) collection.
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI:31941; Oxaliplatin (Elotaxin; L-OHP).
CC   Sequence variation: Mutation; HGNC; 7989; NRAS; Simple; p.Gln61Lys (c.181C>A); ClinVar=VCV000073058; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1700 ! SK-N-AS
SX   Female
AG   6Y
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 05-10-23; Version: 12
//
RX   PubMed=28192521; DOI=10.1371/journal.pone.0172140;
RA   Saintas E., Abrahams L., Ahmad G.T., Ajakaiye A.-O.M., AlHumaidi A.S.H.A.M.,
RA   Ashmore-Harris C., Clark I., Dura U.K., Fixmer C.N., Ike-Morris C.,
RA   Mato Prado M., McCullough D., Mishra S., Scholer K.M.U., Timur H.,
RA   Williamson M.D.C., Alatsatianos M., Bahsoun B., Blackburn E.,
RA   Hogwood C.E., Lithgow P.E., Rowe M., Yiangou L., Rothweiler F.,
RA   Cinatl J. Jr., Zehner R., Baines A.J., Garrett M.D., Gourlay C.W.,
RA   Griffin D.K., Gullick W.J., Hargreaves E., Howard M.J., Lloyd D.R.,
RA   Rossman J.S., Smales C.M., Tsaousis A.D., von der Haar T., Wass M.N.,
RA   Michaelis M.;
RT   "Acquired resistance to oxaliplatin is not directly associated with
RT   increased resistance to DNA damage in SK-N-ASrOXALI4000, a newly
RT   established oxaliplatin-resistant sub-line of the neuroblastoma cell
RT   line SK-N-AS.";
RL   PLoS ONE 12:E0172140-E0172140(2017).
//